Flyrcado

What is this medication?

Flyrcado, generically known as flurpiridaz F 18, is a prescription radiopharmaceutical used as a diagnostic tool for imaging the heart. It is specifically indicated for use in positron emission tomography myocardial perfusion imaging, commonly referred to as PET MPI. This medication is used in adult patients with known or suspected coronary artery disease to assess the blood flow through the heart muscle. By helping to visualize the heart under both resting and exercise or pharmacologically induced stress conditions, it allows doctors to identify areas where blood supply might be restricted.

The drug works by concentrating in the heart tissue in proportion to the amount of blood flow it receives, which is then captured by a PET scanner to create detailed images. Using the fluorine-18 radioisotope, Flyrcado provides high-resolution pictures that can help in the detection and evaluation of heart disease. Because it contains a radioactive component, it is administered only by trained healthcare professionals in specialized medical facilities. This imaging process is vital for determining the severity of heart conditions and guiding subsequent treatment decisions for the patient.